irritable bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: I. Individuals aged 18 to 75 years, regardless of gender; II. Subjects meeting the Rome IV diagnostic criteria for irritable bowel syndrome (IBS); III. Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) score =75 points and Hospital Anxiety and Depression Scale (HADS) score =11 points; IV. No suicidal behavior within the past 3 months or Revised Suicide Behavior Questionnaire (SBQ-R) score <7 points; V. Potential subjects must not have received acupuncture treatment for IBS or taken psychiatric medications within the past six months; VI. If subjects are currently taking medications to alleviate IBS symptoms (e.g., traditional Chinese medicine, proprietary Chinese medicines, antidiarrheals, antispasmodics, intestinal antibiotics, or probiotic preparations) prior to treatment initiation, these must be discontinued at least two weeks before treatment begins.
Exclusion criteria
Exclusion criteria: 1) Organic intestinal diseases such as inflammatory bowel disease, microscopic colitis, celiac disease history, or Crohn's disease; 2) Diabetes mellitus, thyroid dysfunction; 3) Severe acute/chronic organic diseases, renal disease, or hepatic disease; 4) History of abdominal surgery (patients with appendectomy, hemorrhoidectomy, or polypectomy performed over 3 months prior may be included); 5) Pregnancy or lactation; 6) History of alcohol or substance abuse; 7) Patients currently participating in other clinical trials, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the effective response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| IBS-SSS;HADS;Abdominal pain;Satisfaction of bowel habits; | — |
Countries
China
Contacts
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences